Skip to main content
PMC home page
The Western Journal of Medicine logoLink to The Western Journal of Medicine
. 1989 Nov;151(5):530–535.

Cardiac abnormalities in liver cirrhosis.

S S Lee
PMCID: PMC1026787  PMID: 2690463

Abstract

Cirrhosis is associated with several circulatory abnormalities. A hyperkinetic circulation characterized by increased cardiac output and decreased arterial pressure and peripheral resistance is typical. Despite this hyperkinetic circulation, some patients with alcoholic cirrhosis have subclinical cardiomyopathy with evidence of abnormal ventricular function unmasked by physiologic or pharmacologic stress. Florid congestive alcoholic cardiomyopathy develops in a small percentage, but the concurrent presence of cirrhosis seems to retard the occurrence of overt heart failure. Even nonalcoholic cirrhosis may be associated with latent cardiomyopathy, although overt heart failure is not observed. Tense ascites is associated with some cardiac compromise, and removing or mobilizing ascitic fluid by paracentesis or peritoneovenous shunting results in short-term increases in cardiac output. Cirrhosis also appears to be associated with a decreased risk of major coronary atherosclerosis and an increased risk of bacterial endocarditis. Small hemodynamically insignificant pericardial effusions may be seen in ascitic patients. The release of atrial natriuretic peptide appears to be unimpaired in cirrhosis, although the kidney may be hyporesponsive to its natriuretic effects.

Full text

PDF
533

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alderman E. L., Coltart D. J. Alcohol and the heart. Br Med Bull. 1982 Jan;38(1):77–80. doi: 10.1093/oxfordjournals.bmb.a071738. [DOI] [PubMed] [Google Scholar]
  2. Askanas A., Udoshi M., Sadjadi S. A. The heart in chronic alcoholism: a noninvasive study. Am Heart J. 1980 Jan;99(1):9–16. doi: 10.1016/0002-8703(80)90309-9. [DOI] [PubMed] [Google Scholar]
  3. Baudet M., Rigaud M., Rocha P., Bardet J., Bourdarias J. P. Reversibility of alcoholic cardiomyopathy with abstention from alcohol. Cardiology. 1979;64(5):317–324. doi: 10.1159/000170629. [DOI] [PubMed] [Google Scholar]
  4. Benoit J. N., Barrowman J. A., Harper S. L., Kvietys P. R., Granger D. N. Role of humoral factors in the intestinal hyperemia associated with chronic portal hypertension. Am J Physiol. 1984 Nov;247(5 Pt 1):G486–G493. doi: 10.1152/ajpgi.1984.247.5.G486. [DOI] [PubMed] [Google Scholar]
  5. Bernardi M., Trevisani F., Santini C., Zoli G., Baraldini M., Ligabue A., Gasbarrini G. Plasma norepinephrine, weak neurotransmitters, and renin activity during active tilting in liver cirrhosis: relationship with cardiovascular homeostasis and renal function. Hepatology. 1983 Jan-Feb;3(1):56–64. doi: 10.1002/hep.1840030109. [DOI] [PubMed] [Google Scholar]
  6. Blendis L. M., Greig P. D., Langer B., Baigrie R. S., Ruse J., Taylor B. R. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites. Gastroenterology. 1979 Aug;77(2):250–257. [PubMed] [Google Scholar]
  7. Bomzon A., Lee S. S. The jaundiced heart. Hepatology. 1988 Mar-Apr;8(2):434–435. doi: 10.1002/hep.1840080249. [DOI] [PubMed] [Google Scholar]
  8. Bosch J., Arroyo V., Betriu A., Mas A., Carrilho F., Rivera F., Navarro-Lopez F., Rodes J. Hepatic hemodynamics and the renin-angiotensin-aldosterone system in cirrhosis. Gastroenterology. 1980 Jan;78(1):92–99. [PubMed] [Google Scholar]
  9. Bosch J., Enriquez R., Groszmann R. J., Storer E. H. Chronic bile duct ligation in the dog: hemodynamic characterization of a portal hypertensive model. Hepatology. 1983 Nov-Dec;3(6):1002–1007. doi: 10.1002/hep.1840030618. [DOI] [PubMed] [Google Scholar]
  10. Braillon A., Cales P., Valla D., Gaudy D., Geoffroy P., Lebrec D. Influence of the degree of liver failure on systemic and splanchnic haemodynamics and on response to propranolol in patients with cirrhosis. Gut. 1986 Oct;27(10):1204–1209. doi: 10.1136/gut.27.10.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Braillon A., Lee S. S., Girod C., Peignoux-Martinot M., Valla D., Lebrec D. Role of portasystemic shunts in the hyperkinetic circulation of the portal hypertensive rat. J Lab Clin Med. 1986 Dec;108(6):543–548. [PubMed] [Google Scholar]
  12. Bristow M. R., Ginsburg R., Minobe W., Cubicciotti R. S., Sageman W. S., Lurie K., Billingham M. E., Harrison D. C., Stinson E. B. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med. 1982 Jul 22;307(4):205–211. doi: 10.1056/NEJM198207223070401. [DOI] [PubMed] [Google Scholar]
  13. Brodde O. E., Kretsch R., Ikezono K., Zerkowski H. R., Reidemeister J. C. Human beta-adrenoceptors: relation of myocardial and lymphocyte beta-adrenoceptor density. Science. 1986 Mar 28;231(4745):1584–1585. doi: 10.1126/science.3006250. [DOI] [PubMed] [Google Scholar]
  14. CLAYPOOL J. G., DELP M., LIN T. K. Hemodynamic studies in patients with Laennec's cirrhosis. Am J Med Sci. 1957 Jul;234(1):48–passim. doi: 10.1097/00000441-195707000-00006. [DOI] [PubMed] [Google Scholar]
  15. CREED D. L., BAIRD W. F., FISHER E. R. The severity of aortic arteriosclerosis in certain diseases; a necropsy study. Am J Med Sci. 1955 Oct;230(4):385–391. doi: 10.1097/00000441-195510000-00004. [DOI] [PubMed] [Google Scholar]
  16. Cain S. M. Peripheral oxygen uptake and delivery in health and disease. Clin Chest Med. 1983 May;4(2):139–148. [PubMed] [Google Scholar]
  17. Cummings S. A., Groszmann R. J., Kaumann A. J. Hypersensitivity of mesenteric veins to 5-hydroxytryptamine- and ketanserin-induced reduction of portal pressure in portal hypertensive rats. Br J Pharmacol. 1986 Nov;89(3):501–513. doi: 10.1111/j.1476-5381.1986.tb11150.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. DeMeo A. N., Andersen B. R. Defective chemotaxis associated with a serum inhibitor in cirrhotic patients. N Engl J Med. 1972 Apr 6;286(14):735–740. doi: 10.1056/NEJM197204062861401. [DOI] [PubMed] [Google Scholar]
  19. Decaux G., Cauchie P., Soupart A., Kruger M., Delwiche F. Role of vagal neuropathy in the hyponatraemia of alcoholic cirrhosis. Br Med J (Clin Res Ed) 1986 Dec 13;293(6561):1534–1536. doi: 10.1136/bmj.293.6561.1534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Even P., Nicollo F., Benhamou J. P., Fauvert R. Le débit cardiaque au cours des maladies du foie. Effets de l'anastomose porto-cave et des diurétiques. Rev Int Hepatol. 1966;16(4):955–983. [PubMed] [Google Scholar]
  21. GRANT W. C., WASSERMAN F., RODENSKY P. L., THOMSON R. V. The incidence of myocardial infarction in portal cirrhosis. Ann Intern Med. 1959 Oct;51:774–779. doi: 10.7326/0003-4819-51-4-774. [DOI] [PubMed] [Google Scholar]
  22. Gerbes A. L., Arendt R. M., Paumgartner G. Atrial natriuretic factor. Possible implications in liver disease. J Hepatol. 1987 Aug;5(1):123–132. doi: 10.1016/s0168-8278(87)80070-3. [DOI] [PubMed] [Google Scholar]
  23. Gerbes A. L., Remien J., Jüngst D., Sauerbruch T., Paumgartner G. Evidence for down-regulation of beta-2-adrenoceptors in cirrhotic patients with severe ascites. Lancet. 1986 Jun 21;1(8495):1409–1411. doi: 10.1016/s0140-6736(86)91556-4. [DOI] [PubMed] [Google Scholar]
  24. Ginsberg H., Olefsky J., Farquhar J. W., Reaven G. M. Moderate ethanol ingestion and plasma triglyceride levels. A study in normal and hypertriglyceridemic persons. Ann Intern Med. 1974 Feb;80(2):143–149. doi: 10.7326/0003-4819-80-2-143. [DOI] [PubMed] [Google Scholar]
  25. Ginès P., Jiménez W., Arroyo V., Navasa M., López C., Titó L., Serra A., Bosch J., Sanz G., Rivera F. Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology. 1988 May-Jun;8(3):636–642. doi: 10.1002/hep.1840080333. [DOI] [PubMed] [Google Scholar]
  26. Ginés P., Arroyo V., Quintero E., Planas R., Bory F., Cabrera J., Rimola A., Viver J., Camps J., Jiménez W. Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study. Gastroenterology. 1987 Aug;93(2):234–241. doi: 10.1016/0016-5085(87)91007-9. [DOI] [PubMed] [Google Scholar]
  27. Gould L., Shariff M., Zahir M., Di Lieto M. Cardiac hemodynamics in alcoholic patients with chronic liver disease and a presystolic gallop. J Clin Invest. 1969 May;48(5):860–868. doi: 10.1172/JCI106044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Green J., Beyar R., Sideman S., Mordechovitz D., Better O. S. The "jaundiced heart": a possible explanation for postoperative shock in obstructive jaundice. Surgery. 1986 Jul;100(1):14–20. [PubMed] [Google Scholar]
  29. Greig P. D., Blendis L. M., Langer B., Taylor B. R., Colapinto R. F. Renal and hemodynamic effects of the peritoneovenous shunt. II. Long-term effects. Gastroenterology. 1981 Jan;80(1):119–125. [PubMed] [Google Scholar]
  30. Guazzi M., Polese A., Magrini F., Fiorentini C., Olivari M. T. Negative influences of ascites on the cardiac function of cirrhotic patients. Am J Med. 1975 Aug;59(2):165–170. doi: 10.1016/0002-9343(75)90350-2. [DOI] [PubMed] [Google Scholar]
  31. Gurll N. J., Reynolds D. G., Coon D., Shirazi S. S. Acute and chronic splanchnic blood flow responses to portacaval shunt in the normal dog. Gastroenterology. 1980 Jun;78(6):1432–1436. [PubMed] [Google Scholar]
  32. Hadengue A., Lee S. S., Moreau R., Braillon A., Lebrec D. Beneficial hemodynamic effects of ketanserin in patients with cirrhosis: possible role of serotonergic mechanisms in portal hypertension. Hepatology. 1987 Jul-Aug;7(4):644–647. doi: 10.1002/hep.1840070405. [DOI] [PubMed] [Google Scholar]
  33. Haskell L. P., Nidus B. D. Pericardial friction rubs in hepatorenal failure. Lancet. 1987 Jan 3;1(8523):52–52. doi: 10.1016/s0140-6736(87)90754-9. [DOI] [PubMed] [Google Scholar]
  34. Henriksen J. H., Ring-Larsen H., Christensen N. J. Sympathetic nervous activity in cirrhosis. A survey of plasma catecholamine studies. J Hepatol. 1985;1(1):55–65. doi: 10.1016/s0168-8278(85)80068-4. [DOI] [PubMed] [Google Scholar]
  35. Huet P. M., Pomier-Layrargues G., Villeneuve J. P., Varin F., Viallet A. Intrahepatic circulation in liver disease. Semin Liver Dis. 1986 Nov;6(4):277–286. doi: 10.1055/s-2008-1040610. [DOI] [PubMed] [Google Scholar]
  36. Hunt S., Vaamonde C. A., Rattassi T., Berian G., Said S. I., Papper S. Circulating levels of vasoactive intestinal polypeptide in liver disease. Arch Intern Med. 1979 Sep;139(9):994–996. [PubMed] [Google Scholar]
  37. Jahn C. E., Schaefer E. J., Taam L. A., Hoofnagle J. H., Lindgren F. T., Albers J. J., Jones E. A., Brewer H. B., Jr Lipoprotein abnormalities in primary biliary cirrhosis. Association with hepatic lipase inhibition as well as altered cholesterol esterification. Gastroenterology. 1985 Dec;89(6):1266–1278. [PubMed] [Google Scholar]
  38. Jensen L. S., Krarup N., Larsen J. A., Juhl C., Nielsen T. H., Dybdahl H. Chronic portal venous hypertension. The effect on liver blood flow and liver function and the development of esophageal varices. Scand J Gastroenterol. 1987 May;22(4):463–470. doi: 10.3109/00365528708991492. [DOI] [PubMed] [Google Scholar]
  39. KONTOS H. A., SHAPIRO W., MAUCK H. P., PATTERSON J. L., Jr GENERAL AND REGIONAL CIRCULATORY ALTERATIONS IN CIRRHOSIS OF THE LIVER. Am J Med. 1964 Oct;37:526–535. doi: 10.1016/0002-9343(64)90066-x. [DOI] [PubMed] [Google Scholar]
  40. KOWALSKI H. J., ABELMANN W. H., McNEELY W. F. The cardiac output in patients with cirrhosis of the liver and tense ascites with observations on the effect of paracentesis. J Clin Invest. 1954 May;33(5):768–773. doi: 10.1172/JCI102946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. KOWALSKI H. J., ABELMANN W. H. The cardiac output at rest in Laennec's cirrhosis. J Clin Invest. 1953 Oct;32(10):1025–1033. doi: 10.1172/JCI102813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Kelbaek H., Eriksen J., Brynjolf I., Raboel A., Lund J. O., Munck O., Bonnevie O., Godtfredsen J. Cardiac performance in patients with asymptomatic alcoholic cirrhosis of the liver. Am J Cardiol. 1984 Oct 1;54(7):852–855. doi: 10.1016/s0002-9149(84)80220-9. [DOI] [PubMed] [Google Scholar]
  43. Klatsky A. L., Friedman G. D., Siegelaub A. B. Alcohol consumption before myocardial infarction. Results from the Kaiser-Permanente epidemiologic study of myocardial infarction. Ann Intern Med. 1974 Sep;81(3):294–301. doi: 10.7326/0003-4819-81-3-294. [DOI] [PubMed] [Google Scholar]
  44. Knauer C. M., Lowe H. M. Hemodynamics in the cirrhotic patient during paracentesis. N Engl J Med. 1967 Mar 2;276(9):491–496. doi: 10.1056/NEJM196703022760903. [DOI] [PubMed] [Google Scholar]
  45. Koide T., Machida K., Nakanishi A., Ozeki K., Mashima S. Cardiac abnormalities in chronic alcoholism. An evidence suggesting association of myocardial abnormality with chronic alcoholism in 107 Japanese patients admitted to a psychiatric ward. Jpn Heart J. 1972 Sep;13(5):418–427. [PubMed] [Google Scholar]
  46. LOYKE H. F. The relationship of cirrhosis of the liver to hypertension: a study of 504 cases of cirrhosis of the liver. Am J Med Sci. 1955 Dec;230(6):627–632. doi: 10.1097/00000441-195523060-00004. [DOI] [PubMed] [Google Scholar]
  47. LUNSETH J. H., OLMSTEAD E. G., ABBOUD F. A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis. AMA Arch Intern Med. 1958 Sep;102(3):405–413. doi: 10.1001/archinte.1958.00030010405009. [DOI] [PubMed] [Google Scholar]
  48. Lahnborg G., Friman L., Berghem L. Reticuloendothelial function in patients with alcoholic liver cirrhosis. Scand J Gastroenterol. 1981;16(4):481–489. doi: 10.3109/00365528109182002. [DOI] [PubMed] [Google Scholar]
  49. Lebrec D., Bataille C., Bercoff E., Valla D. Hemodynamic changes in patients with portal venous obstruction. Hepatology. 1983 Jul-Aug;3(4):550–553. doi: 10.1002/hep.1840030412. [DOI] [PubMed] [Google Scholar]
  50. Lee S. S., Braillon A., Girod C., Geoffroy P., Lebrec D. Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats. J Hepatol. 1986;3(1):38–41. doi: 10.1016/s0168-8278(86)80143-x. [DOI] [PubMed] [Google Scholar]
  51. Lee S. S., Girod C., Braillon A., Hadengue A., Lebrec D. Hemodynamic characterization of chronic bile duct-ligated rats: effect of pentobarbital sodium. Am J Physiol. 1986 Aug;251(2 Pt 1):G176–G180. doi: 10.1152/ajpgi.1986.251.2.G176. [DOI] [PubMed] [Google Scholar]
  52. Lee S. S., Girod C., Valla D., Geoffroy P., Lebrec D. Effects of pentobarbital sodium anesthesia on splanchnic hemodynamics of normal and portal-hypertensive rats. Am J Physiol. 1985 Oct;249(4 Pt 1):G528–G532. doi: 10.1152/ajpgi.1985.249.4.G528. [DOI] [PubMed] [Google Scholar]
  53. Lee S. S., Hadengue A., Moreau R., Sayegh R., Hillon P., Lebrec D. Postprandial hemodynamic responses in patients with cirrhosis. Hepatology. 1988 May-Jun;8(3):647–651. doi: 10.1002/hep.1840080335. [DOI] [PubMed] [Google Scholar]
  54. Lee S. S., Moreau R., Hadengue A., Cerini R., Koshy A., Lebrec D. Glucagon selectively increases splanchnic blood flow in patients with well-compensated cirrhosis. Hepatology. 1988 Nov-Dec;8(6):1501–1505. doi: 10.1002/hep.1840080606. [DOI] [PubMed] [Google Scholar]
  55. Lenz K., Hörtnagl H., Magometschnigg D., Kleinberger G., Druml W., Laggner A. Function of the autonomic nervous system in patients with hepatic encephalopathy. Hepatology. 1985 Sep-Oct;5(5):831–836. doi: 10.1002/hep.1840050521. [DOI] [PubMed] [Google Scholar]
  56. Levi J. U., Zeppa R., Hutson D. G., Civetta J. M., Ono J., Smith J. P., Etling T. Early hemodynamic effects of the distal splenorenal shunt. Surg Forum. 1976;27(62):370–371. [PubMed] [Google Scholar]
  57. Levy M., Maher E., Wexler M. J. Euvolemic cirrhotic dogs in sodium balance maintain normal systemic hemodynamics. Can J Physiol Pharmacol. 1988 Jan;66(1):80–83. doi: 10.1139/y88-015. [DOI] [PubMed] [Google Scholar]
  58. Lieberman F. L., Reynolds T. B. Plasma volume in cirrhosis of the liver: its relation of portal hypertension, ascites, and renal failure. J Clin Invest. 1967 Aug;46(8):1297–1308. doi: 10.1172/JCI105622. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Limas C. J., Guiha N. H., Lekagul O., Cohn J. N. Impaired left ventricular function in alcoholic cirrhosis with ascites. Ineffectiveness of ouabain. Circulation. 1974 Apr;49(4):754–760. doi: 10.1161/01.cir.49.4.755. [DOI] [PubMed] [Google Scholar]
  60. Lockhart A. Pulmonary arterial hypertension in portal hypertension. Clin Gastroenterol. 1985 Jan;14(1):123–138. [PubMed] [Google Scholar]
  61. Lunzer M. R., Newman S. P., Bernard A. G., Manghani K. K., Sherlock S. P., Ginsburg J. Impaired cardiovascular responsiveness in liver disease. Lancet. 1975 Aug 30;2(7931):382–385. doi: 10.1016/s0140-6736(75)92896-2. [DOI] [PubMed] [Google Scholar]
  62. Lunzer M., Newman S. P., Sherlock S. Skeletal muscle blood flow and neurovascular reactivity in liver disease. Gut. 1973 May;14(5):354–359. doi: 10.1136/gut.14.5.354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. MAINLAND D. The risk of fallacious conclusions from autopsy data on the incidence of diseases with applications to heart disease. Am Heart J. 1953 May;45(5):644–654. doi: 10.1016/0002-8703(53)90306-8. [DOI] [PubMed] [Google Scholar]
  64. MASHFORD M. L., MAHON W. A., CHALMERS T. C. Studies of the cardiovascular system in the hypotension of liver failure. N Engl J Med. 1962 Nov 22;267:1071–1074. doi: 10.1056/NEJM196211222672105. [DOI] [PubMed] [Google Scholar]
  65. MURRAY J. F., DAWSON A. M., SHERLOCK S. Circulatory changes in chronic liver disease. Am J Med. 1958 Mar;24(3):358–367. doi: 10.1016/0002-9343(58)90322-x. [DOI] [PubMed] [Google Scholar]
  66. Massumi R. A., Rios J. C., Ticktin H. E. Hemodynamic abnormalities and venous admixture in portal cirrhosis. Am J Med Sci. 1965 Sep;250(3):275–283. doi: 10.1097/00000441-196509000-00005. [DOI] [PubMed] [Google Scholar]
  67. McDonald C. D., Burch G. E., Walsh J. J. Alcoholic cardiomyopathy managed with prolonged bed rest. Ann Intern Med. 1971 May;74(5):681–691. doi: 10.7326/0003-4819-74-5-681. [DOI] [PubMed] [Google Scholar]
  68. Mikulic E., Muñoz C., Puntoni L. E., Lebrec D. Hemodynamic effects of dobutamine in patients with alcoholic cirrhosis. Clin Pharmacol Ther. 1983 Jul;34(1):56–59. doi: 10.1038/clpt.1983.129. [DOI] [PubMed] [Google Scholar]
  69. Mooney C. S., Honaker A. D., Griffen W. O., Jr Influence of the liver on arteriovenous fistulas. Arch Surg. 1970 Feb;100(2):154–156. doi: 10.1001/archsurg.1970.01340200042010. [DOI] [PubMed] [Google Scholar]
  70. Moreau R., Lee S. S., Hadengue A., Ozier Y., Sicot C., Lebrec D. Relationship between oxygen transport and oxygen uptake in patients with cirrhosis: effects of vasoactive drugs. Hepatology. 1989 Mar;9(3):427–432. doi: 10.1002/hep.1840090314. [DOI] [PubMed] [Google Scholar]
  71. Moreau R., Lee S. S., Soupison T., Roche-Sicot J., Sicot C. Abnormal tissue oxygenation in patients with cirrhosis and liver failure. J Hepatol. 1988 Aug;7(1):98–105. doi: 10.1016/s0168-8278(88)80512-9. [DOI] [PubMed] [Google Scholar]
  72. Needleman P. Atriopeptin biochemical pharmacology. Fed Proc. 1986 Jun;45(7):2096–2100. [PubMed] [Google Scholar]
  73. RAAB W. Key position of catecholamines in functional and degenerative cardiovascular pathology. Am J Cardiol. 1960 May;5:571–578. doi: 10.1016/0002-9149(60)90121-1. [DOI] [PubMed] [Google Scholar]
  74. Ramond M. J., Comoy E., Lebrec D. Alterations in isoprenaline sensitivity in patients with cirrhosis: evidence of abnormality of the sympathetic nervous activity. Br J Clin Pharmacol. 1986 Feb;21(2):191–196. doi: 10.1111/j.1365-2125.1986.tb05174.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Regan T. J., Levinson G. E., Oldewurtel H. A., Frank M. J., Weisse A. B., Moschos C. B. Ventricular function in noncardiacs with alcoholic fatty liver: role of ethanol in the production of cardiomyopathy. J Clin Invest. 1969 Feb;48(2):397–407. doi: 10.1172/JCI105997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  76. SHOZAWA T., OTSU S. PATHOLOGY OF THE MYOCARDIUM IN CASES OF CHRONIC LIVER DISEASE, ESPECIALLY OF LIVER CIRRHOSIS. Jpn Circ J. 1964 Mar;28:163–170. [PubMed] [Google Scholar]
  77. Salerno F., Badalamenti S., Incerti P., Capozza L., Mainardi L. Renal response to atrial natriuretic peptide in patients with advanced liver cirrhosis. Hepatology. 1988 Jan-Feb;8(1):21–26. doi: 10.1002/hep.1840080106. [DOI] [PubMed] [Google Scholar]
  78. Schrier R. W. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy (2) N Engl J Med. 1988 Oct 27;319(17):1127–1134. doi: 10.1056/NEJM198810273191705. [DOI] [PubMed] [Google Scholar]
  79. Schwartz L., Sample K. A., Wigle D. E. Severe alcoholic cardiomyopathy reversed with abstention from alcohol. Am J Cardiol. 1975 Dec;36(7):963–966. doi: 10.1016/0002-9149(75)90090-9. [DOI] [PubMed] [Google Scholar]
  80. Shah A., Variyam E. Pericardial effusion and left ventricular dysfunction associated with ascites secondary to hepatic cirrhosis. Arch Intern Med. 1988 Mar;148(3):585–588. [PubMed] [Google Scholar]
  81. Siegel J. H., Goldwyn R. M., Farrell E. J., Gallin P., Friedman H. P. Hyperdynamic states and the physiologic determinants of survival in patients with cirrhosis and portal hypertension. Arch Surg. 1974 Mar;108(3):282–292. doi: 10.1001/archsurg.1974.01350270016004. [DOI] [PubMed] [Google Scholar]
  82. Simon D. M., McCain J. R., Bonkovsky H. L., Wells J. O., Hartle D. K., Galambos J. T. Effects of therapeutic paracentesis on systemic and hepatic hemodynamics and on renal and hormonal function. Hepatology. 1987 May-Jun;7(3):423–429. doi: 10.1002/hep.1840070302. [DOI] [PubMed] [Google Scholar]
  83. Snyder N., Atterbury C. E., Pinto Correia J., Conn H. O. Increased concurrence of cirrhosis and bacterial endocarditis. A clinical and postmortem study. Gastroenterology. 1977 Nov;73(5):1107–1113. [PubMed] [Google Scholar]
  84. Spodick D. H., Pigott V. M., Chirife R. Preclinical cardiac malfunction in chronic alcoholism. Comparison with matched normal controls and with alcoholic cardiomyopathy. N Engl J Med. 1972 Oct 5;287(14):677–680. doi: 10.1056/NEJM197210052871401. [DOI] [PubMed] [Google Scholar]
  85. Triger D. R., Wright R. Hyperglobulinaemia in liver disease. Lancet. 1973 Jun 30;1(7818):1494–1496. doi: 10.1016/s0140-6736(73)91827-8. [DOI] [PubMed] [Google Scholar]
  86. Valla D., Poynard T., Bercoff E., Bataille C., Goldfarb G., Lebrec D. Le syndrome d'hypercinésie circulatoire systémique chez les malades atteints de cirrhose. Relations avec l'insuffisance hépatocellulaire et l'hypertension portale. Gastroenterol Clin Biol. 1984 Apr;8(4):321–324. [PubMed] [Google Scholar]
  87. WARREN J. V., NICKERSON J. L., ELKIN D. C. The cardiac output in patients with arteriovenous fistulas. J Clin Invest. 1951 Feb;30(2):210–214. doi: 10.1172/JCI102434. [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Wise W. J., Mamdani B. H., Bakir A. A., Dunea G. Fibrinous pericarditis in hepatorenal failure. Lancet. 1980 Dec 20;2(8208-8209):1336–1337. doi: 10.1016/s0140-6736(80)92400-9. [DOI] [PubMed] [Google Scholar]
  89. Yang S. S., Kanel G. Fibrinous pericarditis in alcoholic liver disease. J Clin Gastroenterol. 1989 Feb;11(1):53–55. doi: 10.1097/00004836-198902000-00012. [DOI] [PubMed] [Google Scholar]
  90. Yano K., Rhoads G. G., Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med. 1977 Aug 25;297(8):405–409. doi: 10.1056/NEJM197708252970801. [DOI] [PubMed] [Google Scholar]

Articles from Western Journal of Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES